Sentence examples for malaria component from inspiring English sources

Algeria, Libya and Egypt are included for the review of HIV NSPs and Global Fund proposals but excluded from the malaria component as malaria is not prevalent in those countries.

These results reflect the perspective of a payer who assumes responsibility for the diarrhoea and malaria components only.

The objective of this article is to analyse the current HIV and malaria NSPs as well as approved Global Fund proposals with HIV and/or malaria components from rounds 1-8 for countries in Africa hosting populations of ≥ 10,000 refugees and/or IDPs and to document their inclusion.

Looking at the budget proportions per expenditure targets reveals a decrease in investment in human resources for health and training in Round 4. A recent study of all malaria components over all four Rounds also reveals a decline in allocation to human resources and training towards Round 4 [ 18].

Chisholm, S. A. et al. The malaria PTEX component PTEX88 interacts most closely with HSP101 at the host-parasite interface.

The Lubombo Spatial Development Initiative (LSDI), a development program between the governments of Mozambique, South Africa, and Swaziland with a large malaria prevention component, demonstrated the value of this approach.

The present study demonstrates that three immunizations with the virosomal malaria vaccine components PEV301 or/and PEV302 (containing 10 µg or 50 µg of antigen) are safe and well tolerated.

Only accepted Global Fund proposals with a malaria and/or HIV component were included.

These data suggest that an MSP2 based vaccine should be designed to induce high level antibody responses against the different MSP2 types present globally in P. falciparum populations and that MSP2 could be combined with other P. falciparum antigens to form a multi-component malaria vaccine.

Peru, along with other South American countries, is moving to introduce malaria RDTs as components of malaria control programmes supported by the Global Fund for AIDS, TB and malaria.

The current Phase 1/2a study was the first to compare the safety and immunogenicity of an AMA-1-based vaccine in both AS01B and AS02A Adjuvant Systems, and the first to assess the efficacy of such a vaccine in malaria-naïve adults using a homologous primary sporozoite challenge model [21], thus contributing key information to the development process of a multi-component malaria vaccine [22].